Mini Review
Volume 6 Issue 10 - 2020
The Potential and Promising Application of Fullerenes in Pain Management and Anaesthesia
Nicholas A Kerna1*, John V Flores2,3, Kevin D Pruitt4, Uzoamaka Nwokorie5 and HIlary M Holets2,3
1SMC–Medical Research, Thailand
2Beverly Hills Wellness Surgical Institute, USA
3Orange Partners Surgicenter, USA
3Kemet Medical Consultants, USA
3University of Washington, USA
*Corresponding Author: Nicholas A Kerna, POB47 Phatphong, Suriwongse Road, Bangkok, Thailand 10500.
Received: September 08, 2020; Published: October 29, 2020


Fullerene, a carbon-based material, is being beneficially applied in nanotechnology on a limited but expanding basis. Some advantages of fullerene are its ability to react with nucleophiles and undergo various chemical reactions, such as reduction, oxidation, hydrogenation and halogenation. Some disadvantages of fullerene are its susceptibility to degrade in the presence of light and oxygen and decompose due to a shift from the excited singlet state to an energetically lower triplet state. Also, fullerene’s hydrophobic and aggregate-forming characteristics are significantly challenging in its application in medicine. Nevertheless, fullerene has potential applications in managing neuropathic pain and anaesthesia. The stimulation of specific voltage-gated sodium channels results in pain disorders. Fullerene can block the channel pore, demonstrating fullerene’s potential in managing neuropathic pain. In conjunction with nanorobot technology, fullerene might act as an anaesthetic or analgaesic agent and a nanomaterial for dental robots. Pristine C60 is relatively less toxic than other variants of nanocarbons, and in many instances, shows biocompatibility in humans. However, the manufacturing process of experimental-grade nanocarbon onion-like fullerene materials can be inconsistent (even within the same batch). Thus, performing reliable assessments and reproducible studies of their biological benefits, biocompatibility, and potential toxicity are are problematic

Keywords: Allotrope; Anaesthesia; Analgaesic; Buckyball; Fullerene; Isoform hNav1.7


  1. Bakry R., et al. “Medicinal applications of fullerenes”. International Journal of Nanomedicine4 (2007): 639-649.
  2. Bogdanović G and Djordjević A. “Carbon nanomaterials: Biologically active fullerene derivatives”. Srp Arh Celok Lek 3-4 (2016): 222-231.
  3. Bosi S., et al. “Fullerene derivatives: an attractive tool for biological applications”. European Journal of Medicinal Chemistry 11-12 (2003): 913-923.
  4. 25 years of C60. Nature Nanotechnology (2010).
  5. Kroto HW., et al. “C60: Buckminsterfullerene”. Nature 318 (1985): 162-163.
  6. Klein DJ. “Resonance in C60, Buckminsterfullerene”. Journal of the American Chemical Society 108 (1986): 1301-1302.
  7. Yadav J. “Fullerene: Properties, Synthesis and Application”. Research and Reviews: Journal of Physics (2017).
  8. Bartelmess J. “Carbon nano-onions (multi-layer fullerenes): 12. chemistry and applications”. Beilstein Journal of Nanotechnology 5 (2014): 1980-1199.
  9. Khan ZH and Husain M. “Carbon nanotube and its possible applications”. Indian Journal of Engineering and Materials Sciences (2005).
  10. Salata OV. “Applications of nanoparticles in biology and medicine”. Journal of Nanobiotechnology (2004): 2.
  11. Yadav BC and Kumar R. “Structure, properties and applications of fullerenes”. International Journal of Nanotechnology and Applications ISSN (2008).
  12. Chistyakov VA. “Possible Mechanisms of Fullerene C60 Antioxidant Action”. Bio Med Research International 8 (2013): 821498.
  13. “Fullerenes: principles and applications”. Choice Reviews Online (2007).
  14. Montellano López A., et al. “Materials chemistry of fullerene C60 derivatives”. Journal of Materials Chemistry (2011).!divAbstract
  15. Taylor R and Walton DRM. “The chemistry of fullerenes”. Nature (1993).
  16. Hirsch A. “The Chemistry of the Fullerenes” (2008).
  17. Hirsch A and Brettreich M. “Fullerenes: Chemistry and Reactions” (2005).
  18. Fiorito S., et al. “Toxicity and biocompatibility of carbon nanoparticles”. Journal of Nanoscience and Nanotechnology3 (2006): 591-599.
  19. Fard JK. “A Review of Molecular Mechanisms Involved in Toxicity 18. of Nanoparticles”. Advanced Pharmaceutical Bulletin 5 (2015): 447-454.
  20. Kharlamova G., et al. “Toxicology of Heterocarbon and Application of Nanoheterocarbon Materials for CBRN Defense”. In Nanostructured Materials for the Detection of CBRN (2018): 245-277.
  21. King GF and Vetter I. “No gain, no pain: Nav1.7 as an analgesic target”. ACS Chemical Neuroscience9 (2014): 749-751.
  22. Hilder TA., et al. “Functionalized Fullerene Targeting Human Voltage-Gated Sodium Channel, hNav1.7”. ACS Chemical Neuroscience (2017).
  23. Jaspreet S. “Future Prospective of Nano Onions: A Review. In13. Ternational”. Journal of Current Medical and Pharmaceutical Research (2016): 222-234.
  24. Xu BS. “Prospects and research progress in nano onion-like fullerenes”. New Carbon Materials4 (2008): 12.
  25. Kumar S and Vijayalakshmi R. “Nanotechnology in dentistry”. Indian Journal of Dental Research (2006).;year=2006;volume=17;issue=2;spage=62;epage=5;aulast=Kumar
  26. Das A and Nasim I. “Nanotechnology in Dentistry-A Review”. Journal of Advanced Pharmacy Education and Research2 (2017): 43.
  27. AlKahtani RN. “The implications and applications of nanotechnology in dentistry: A review”. The Saudi Dental Journal2 (2018): 107-116.
  28. Zafar MS., et al. “Therapeutic applications of nanotechnology in dentistry”. In Nanostructures for Oral Medicine (2017): 833.
  29. Johnston HJ., et al. “The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity”. Toxicological Sciences (2009).
  30. Kolosnjaj J., et al. “Bio-Applications of Nanoparticles (2007).
  31. Aschberger K., et al. “Review of fullerene toxicity and exposure - Appraisal of a human health risk assessment, based on open literature”. Regulatory Toxicology and Pharmacology3 (2010): 455-473.
  32. Lacerda L., et al. “Carbon nanotubes as nanomedicines: From toxicology to pharmacology”. Advanced Drug Delivery Reviews14 (2006): 1460-1470.
  33. D’Amora M., et al. “Biocompatibility and biodistribution of functionalized carbon nano onions (f-CNOs) in a vertebrate model”. Scientific Reports1 (2016): 1-9.
  34. Kerna NA, Flores JV. The Biocompatibility and Toxicity of Nanocarbon Onion-Like Fullerene (NOLF) Materials in Humans and Living Systems. EC Pharmacology and Toxicology 8.10 (2020): 50-54.
Citation: Kerna NA, Flores JV, Pruitt KD, Nwokorie U, Holets H. The Potential and Promising Application of Fullerenes in Pain Management and Anaesthesia. EC Anaesthesia. 2020 Sep 8; 6.11: 14-18.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.